UNSPSC 85681521: Supplement right mandible with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right mandible with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0NUT37Z

UNSPSC 85681521 Supplement right mandible with autologous tissue substitute, percutaneous approach is a Commodity code that describes a specific surgical procedure involving mandibular reconstruction with autologous tissue. State and local procurement activity under this code shows little alignment with the code's nominal scope. Recent opportunities tagged to this code address occupational medical surveillance, pharmacy benefit management, independent medical evaluations for pension disability determinations, surgical benefit carve-out programs, and temporary health professional staffing — none of which involve mandibular reconstruction or surgical tissue grafting. The issuing bodies include state transportation departments, counties, cities, and county health systems procuring medical administration, benefits management, and staffing services rather than the orthognathic or reconstructive surgical procedures the code nominally describes. This pattern suggests the code may be misapplied to medical services procurement at the state and local level, or the taxonomy assignment is inconsistent with actual scope of work.

The recent opportunities span Washington State (Washington State Department of Transportation occupational medical surveillance), California (City of Long Beach surgical benefit carve-out and County of Santa Clara temporary health professional staffing), Arizona (City of Phoenix independent medical evaluations), Texas (Harris County Juvenile Probation Department specialty medical services RFI), and Florida (Collier County pharmacy benefit management). Response dates cluster between September and November 2026, with the largest opportunity being Collier County's pharmacy benefit management RFP due April 9, 2026, valued at approximately $8.7 million annually. Because these opportunities reflect medical administration, benefits contracting, and staffing rather than the surgical reconstruction the code nominally covers, this code shows minimal relevant procurement activity for vendors specializing in mandibular augmentation or autologous tissue grafting.